MRI features of molecular glioblastoma: morphological and advanced imaging insights
European Journal of Radiology · 2026
DOI: 10.1016/j.ejrad.2026.112692 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Radiology, 2026. Verfasst von Margaux Roques und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroradiology, Toulouse Purpan University Hospital, Toulouse, France. Electronic address: roques.marg@chu-toulouse.fr. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: IDH-wildtype diffuse gliomas with molecular features of glioblastoma (mGBM) were integrated into the GBM category in the 2021 WHO classification, yet their MRI characteristics remain poorly described. This study aimed to detail morphological and advanced MRI features of mGBM to improve diagnostic accuracy and management. METHODS: MRI scans (1.5 T or 3 T) of 72 patients with histomolecularly confirmed mGBM were retrospectively reviewed. Two neuroradiologists analyzed morphological features (necrosis, contrast enhancement, FLAIR pattern, multilobar involvement) and advanced imaging findings (diffusion, perfusion). RESULTS: Mean patient age was 63 years. mGBMs showed a broad spectrum of MRI appearances, from grade 2-like (39%) to grade 4-like (26%). Infiltrative FLAIR hyperintensity was nearly constant, frequently with multilobar involvement (65%). Contrast enhancement was absent in 39% or faint/limited when present, often mimicking lower-grade gliomas. Gyriform cortical infiltration sparing white matter was seen in 15% of cases, less than previously reported. Advanced imaging showed diffusion restriction in 64% and elevated rCBV (>1.75) in 88% of cases with perfusion data, leading to reclassification of 22% of morphologically grade 2-like lesions as grade 3-like. CONCLUSION: mGBMs often mimic low-grade gliomas, exposing patients to underdiagnosis and treatment delays. However, infiltrative FLAIR abnormalities, multilobar involvement, diffusion restriction, or increased perfusion should raise suspicion, particularly in older patients. This cohort describing both morphological and advanced MRI features of mGBM provides practical imaging criteria to enhance early recognition in routine practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroradiology, Toulouse Purpan University Hospital, Toulouse, France. Electronic address: roques.marg@chu-toulouse.fr.
- Department of Neuroradiology, Toulouse Purpan University Hospital, Toulouse, France.
- Department of Pathology, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
- Department of Radiotherapy, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
- Department of Neurosurgery, Toulouse Purpan University Hospital, Toulouse, France.
Zitieren
APA
Roques, M., Pimentel, K., Siegfried-Vergnon, A., Moyal, E., Zerbib, C., Barros, A., Raveneau, M., Dghayem, D., & Bonneville, F. (2026). MRI features of molecular glioblastoma: morphological and advanced imaging insights. European Journal of Radiology. https://doi.org/10.1016/j.ejrad.2026.112692
Vancouver
Roques M, Pimentel K, Siegfried-Vergnon A, Moyal E, Zerbib C, Barros A, et al. MRI features of molecular glioblastoma: morphological and advanced imaging insights. European Journal of Radiology. 2026. doi:10.1016/j.ejrad.2026.112692
BibTeX
@article{Roques2026,
author = {Roques, Margaux and Pimentel, Kevin and Siegfried-Vergnon, Aurore and Moyal, Elizabeth and Zerbib, Caroline and Barros, Amaury de and Raveneau, Magali and Dghayem, Delphine and Bonneville, Fabrice},
title = {MRI features of molecular glioblastoma: morphological and advanced imaging insights},
journal = {European Journal of Radiology},
year = {2026},
doi = {10.1016/j.ejrad.2026.112692}
}
EUVIMED